Ítems de la colección (ordenados por Fecha Publicación en orden Descendente): 1 a 20 de 186
Vista previa | Fecha de publicación | Fecha de Creación | Título |
 | oct-2024 | - | La reconstrucción posmastectomía y su relación con la radioterapia adyuvante en el tratamiento del cáncer invasivo de mama: ¿asunto cerrado? |
 | oct-2024 | - | Cell-specific extracellular vesicles and their miRNA cargo released Into the organ preservations solution during cold ischemia storage as biomarkers for liver transplant outcomes |
 | 18-jul-2024 | - | GEMA-Na and MELD 3.0 severity scores to address sex disparities for accessing liver transplantation: a nationwide retrospective cohort study |
 | 15-may-2024 | - | AEOL-Induced NRF2 Activation and DWORF Overexpression Mitigate Myocardial I/R Injury |
 | may-2024 | - | Preventing alpelisib-related hyperglycaemia in HR+/HER2−/PIK3CA-mutated advanced breast cancer using metformin (METALLICA): a multicentre, open-label, single-arm, phase 2 trial |
 | 14-abr-2024 | - | Anticipating the side effects of benznidazole: HLA-B*35 and patch test |
 | 13-ene-2024 | - | Circulating blood biomarkers correlated with the prognosis of advanced triple negative breast cancer |
 | oct-2023 | - | Executive summary consensus statement of imported diseases group (GEPI) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the Spanish Society of Tropical Medicine and International Health (SETMSI), on the diagnostic and treatment of imported schistosomiasis |
 | 22-sep-2023 | - | Recurrent genetic variants and prioritization of variants of uncertain clinical significance associated with hereditary breast and ovarian cancer in families from the Region of Murcia |
 | 18-sep-2023 | - | Endothelial cell activation mediated by cold ischemia-released mitochondria is partially inhibited by defibrotide and impacts on early allograft function following liver transplantation |
 | sep-2023 | - | Circulating ST2, from biomarker to pathogenic mediator |
 | 1-ago-2023 | - | HLA-A*11:01 and HLA-C*04:01 are associated with severe COVID-19 |
 | 4-jul-2023 | - | EN-DALBACEN 2.0 Cohort: real-life study of dalbavancin as sequential/consolidation therapy in patients with infective endocarditis due to Gram-positive cocci |
 | 4-jul-2023 | - | EN-DALBACEN 2.0 Cohort: real-life study of dalbavancin as sequential/consolidation therapy in patients with infective
endocarditis due to Gram-positive cocci |
 | 1-jun-2023 | - | Effectiveness of fosfomycin trometamol as oral step-down therapy for bacteraemic urinary tract infections due to MDR Escherichia coli: a post hoc analysis of the FOREST randomized tria |
 | 17-may-2023 | - | GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 |
 | may-2023 | - | Silencing of microRNA-106b-5p prevents doxorubicin-mediated cardiotoxicity through modulation of the PR55α/YY1/sST2 signaling axis |
 | 2023 | - | Neoadjuvant palbociclib plus either giredestrant or anastrozole in oestrogen receptor-positive, HER2-negative, early breast cancer (coopERA Breast Cancer): an open-label, randomised, controlled, phase 2 study |
 | 2023 | - | The Atrial Fibrillation Better Care (ABC) Pathway and Clinical Outcomes in Patients with Atrial Fibrillation: the Prospective Murcia AF Project Phase II Cohort |
 | 2023 | - | Tolerance and adherence of patients with chronic chagas disease treated with benznidazole |
Ítems de la colección (ordenados por Fecha Publicación en orden Descendente): 1 a 20 de 186